Skip to main content
. 2015 Nov 23;14:77–87. doi: 10.1007/s40258-015-0204-3

Fig. 3.

Fig. 3

Cost-effectiveness acceptability curve for varenicline (multiple quit attempts) versus market mix. ¥ Japanese yen, QALY quality-adjusted life-year